VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,373,000 | -87.1% | 128,269 | -50.0% | 6.97% | -77.8% |
| Q4 2015 | $26,077,000 | -10.0% | 256,538 | +58.0% | 31.38% | +5.4% |
| Q3 2015 | $28,968,000 | -30.9% | 162,394 | -14.0% | 29.76% | -14.9% |
| Q2 2015 | $41,943,000 | +6.1% | 188,804 | -5.1% | 34.97% | -12.8% |
| Q1 2015 | $39,527,000 | +38.8% | 199,004 | 0.0% | 40.10% | +20.1% |
| Q4 2014 | $28,479,000 | +14.0% | 199,004 | +4.5% | 33.38% | +11.5% |
| Q3 2014 | $24,981,000 | +4.0% | 190,404 | 0.0% | 29.94% | +1.5% |
| Q2 2014 | $24,014,000 | -4.3% | 190,404 | 0.0% | 29.50% | -0.0% |
| Q1 2014 | $25,101,000 | +12.3% | 190,404 | 0.0% | 29.51% | +5.2% |
| Q4 2013 | $22,353,000 | – | 190,404 | – | 28.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |